These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 39125529)

  • 1. Detection of Hepatic Metastasis from Early Delayed Images of Modified Dual-Time-Point F-18 FDG PET/CT Images in a Patient with Breast Cancer.
    Lee JY; Song HS
    Diagnostics (Basel); 2024 Jul; 14(15):. PubMed ID: 39125529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual time point fluorodeoxyglucose positron emission tomography/computed tomography in differentiation between malignant and benign lesions in cancer patients. Does it always work?
    Saleh Farghaly HR; Mohamed Sayed MH; Nasr HA; Abdelaziz Maklad AM
    Indian J Nucl Med; 2015; 30(4):314-9. PubMed ID: 26430314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of dual-time point
    Pang L; Bo X; Wang J; Wang C; Wang Y; Liu G; Yu H; Chen L; Shi H; Liu H
    Abdom Radiol (NY); 2021 Sep; 46(9):4138-4147. PubMed ID: 33825930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of dual-time-point 18F-FDG PET/CT for identifying axillary lymph node metastasis in breast cancer patients.
    Choi WH; Yoo IR; O JH; Kim SH; Chung SK
    Br J Radiol; 2011 Jul; 84(1003):593-9. PubMed ID: 21081574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-phase F-18 FDG PET-CT in staging and lymphoscintigraphy for detection of sentinel lymph nodes in oral cavity cancers.
    Sürücü E; Polack BD; Demir Y; Durmuşoğlu M; Ekmekçi S; Sarıoğlu S; Çelik AO; Ada E; İkiz AÖ
    Clin Imaging; 2015; 39(5):781-6. PubMed ID: 25721710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early SUV
    Zhang J; Shi X; Xiao Y; Ma C; Cao G; Liu Y; Li Y
    Quant Imaging Med Surg; 2021 May; 11(5):1680-1691. PubMed ID: 33936956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The added value of dual-time-point 18F-FDG PET/CT imaging in the diagnosis of colorectal cancer liver metastases.
    Mao W; Zhou J; Qiu L; Yin H; Tan H; Shi H
    Abdom Radiol (NY); 2020 Apr; 45(4):1075-1081. PubMed ID: 31927618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Clinical Role of Dual-Time-Point (18)F-FDG PET/CT in Differential Diagnosis of the Thyroid Incidentaloma.
    Lee S; Park T; Park S; Pahk K; Rhee S; Cho J; Jeong E; Kim S; Choe JG
    Nucl Med Mol Imaging; 2014 Jun; 48(2):121-9. PubMed ID: 24900152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A first described chest wall metastasis from colon cancer demonstrated with (18)F-FDG PET/CT.
    Jiang L; Gao Y; Sheng S; Xu M; Lu L; Lu H
    Hell J Nucl Med; 2011; 14(3):316-7. PubMed ID: 22087459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing
    Sarikaya I; Sarikaya A
    J Nucl Med Technol; 2019 Jun; 47(2):149-153. PubMed ID: 30413593
    [No Abstract]   [Full Text] [Related]  

  • 12. Whole-body
    Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
    Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of standardized uptake value measurements of the primary lesions in proven cases of breast carcinoma with different degree of disease burden at diagnosis: does 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography predict tumor biology?
    Basu S; Mavi A; Cermik T; Houseni M; Alavi A
    Mol Imaging Biol; 2008; 10(1):62-6. PubMed ID: 18000713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of dual-time
    Pahk K; Chung JH; Kim S; Lee SH
    Tumori; 2018 Jun; 104(3):207-212. PubMed ID: 29714664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-time-point [18F]-FDG PET/CT in the diagnostic evaluation of suspicious breast lesions.
    Caprio MG; Cangiano A; Imbriaco M; Soscia F; Di Martino G; Farina A; Avitabile G; Pace L; Forestieri P; Salvatore M
    Radiol Med; 2010 Mar; 115(2):215-24. PubMed ID: 20017002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dual-time point images of the liver with (18)F-FDG PET/CT in suspected recurrence from colorectal cancer].
    Fuster D; Lafuente S; Setoain X; Navales I; Perissinotti A; Pavia J; Paredes P; Lomeña F; Pons F
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):111-6. PubMed ID: 22154291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-stop [
    Liu G; Mao W; Yu H; Hu Y; Gu J; Shi H
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2271-2281. PubMed ID: 36971806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual time point [18F]Flurodeoxyglucose (FDG) Positron Emission Tomography (PET)/Computed Tomography (CT) with water gastric distension in differentiation between malignant and benign gastric lesions.
    Farghaly H; Alshareef M; Alqarni A; Sayed M; Nasr H
    Eur J Radiol Open; 2020; 7():100268. PubMed ID: 32964074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal variants of bowel FDG uptake in dual-time-point PET/CT imaging.
    Toriihara A; Yoshida K; Umehara I; Shibuya H
    Ann Nucl Med; 2011 Apr; 25(3):173-8. PubMed ID: 21088936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI and FDG PET/CT findings of hepatic epithelioid hemangioendothelioma.
    Dong A; Dong H; Wang Y; Gong J; Lu J; Zuo C
    Clin Nucl Med; 2013 Feb; 38(2):e66-73. PubMed ID: 22996250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.